| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Hangzhou Coco Healthcare Products Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.10 |
| 52 Week High | CN¥12.87 |
| 52 Week Low | CN¥6.80 |
| Beta | 0.67 |
| 11 Month Change | -1.53% |
| 3 Month Change | -2.87% |
| 1 Year Change | -43.38% |
| 33 Year Change | -69.34% |
| 5 Year Change | n/a |
| Change since IPO | -72.53% |
Recent News & Updates
Shareholder Returns
| 301009 | CN Household Products | CN Market | |
|---|---|---|---|
| 7D | -3.9% | 1.1% | 1.1% |
| 1Y | -43.4% | -27.0% | -20.4% |
Return vs Industry: 301009 underperformed the CN Household Products industry which returned -27% over the past year.
Return vs Market: 301009 underperformed the CN Market which returned -20.4% over the past year.
Price Volatility
| 301009 volatility | |
|---|---|
| 301009 Average Weekly Movement | 4.9% |
| Household Products Industry Average Movement | 4.3% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.5% |
| 10% least volatile stocks in CN Market | 3.6% |
Stable Share Price: 301009 has not had significant price volatility in the past 3 months.
Volatility Over Time: 301009's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 614 | Liwei Jin | www.cocohealthcare.com |
Hangzhou Coco Healthcare Products Co.,Ltd. engages in the research, development, production, and sale of baby care, adult incontinence, and pet care products in China. It offers adult incontinence products, including adult diapers, adult pull-up pants, nursing pads, maternity towels, menstrual pants, absorbent towels, and other products, as well as absorbent towels and absorbent pads for men.
Hangzhou Coco Healthcare Products Co.,Ltd. Fundamentals Summary
| 301009 fundamental statistics | |
|---|---|
| Market cap | CN¥1.91b |
| Earnings (TTM) | CN¥21.51m |
| Revenue (TTM) | CN¥1.04b |
88.6x
P/E Ratio1.8x
P/S RatioIs 301009 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301009 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.04b |
| Cost of Revenue | CN¥841.04m |
| Gross Profit | CN¥198.71m |
| Other Expenses | CN¥177.20m |
| Earnings | CN¥21.51m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.08 |
| Gross Margin | 19.11% |
| Net Profit Margin | 2.07% |
| Debt/Equity Ratio | 0% |
How did 301009 perform over the long term?
See historical performance and comparison